skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Radiopharmaceutical dosimetry in the standard newborn: a model

Conference · · HHS Publ. (FDA) (U.S.); (United States)
OSTI ID:5705802

While there has been an abundance of literature dealing with the absorbed radiation dose from administered radiopharmaceuticals in the standard 70-kg man, a deficiency exists in the availability of this information in the newborn and pediatric population. Direct absorbed dose extrapolation from adult to pediatric patients is not possible. Because of the compactness of the newborn and pediatric human, the absorbed dose per unit may be considerably higher than in the adult population. Before radiopharmaceuticals, particularly investigative new drugs (IND), can be utilized in this age group this data must be available for all the appropriate institutional committees and regulatory bodies. Following the format of the MIRD Committee, a standard newborn model has been constructed. Application of this model allows the user to develop S tables of absorbed dose per cumulated activity for selected radionuclides. This methodology provides for an extension of the tables as presented in NM/MIRD Pamphlet No. 11 for use in this population. Utilizing nuclear data presented in other NM/MIRD pamphlets, this model can be used for dosimetric calculations for most radionuclides after radiobiokinetic data have been collected.

Research Organization:
Univ. of Nebraska Medical Center, Omaha
OSTI ID:
5705802
Report Number(s):
CONF-801082-; TRN: 82-003976
Journal Information:
HHS Publ. (FDA) (U.S.); (United States), Vol. 81-8166; Conference: ORAU radiopharmaceutical dosimetry symposium, Oak Ridge, TN, USA, 6 Oct 1980
Country of Publication:
United States
Language:
English